UNSPSC 41131705: Erythropoietin assay

In this classification a erythropoietin assay is a device that measures the concentration of erythropoietin (an enzyme that regulates the production of red blood cells) in serum or urine. This assay provides diagnostic information for the evaluation of erythrocytosis (increased total red cell mass) and anemia US FDA regulates Erythropoietin assay under 21 CFR 864.7250 and under FDA product code GGT.

UNSPSC 41131705 Erythropoietin assay (Commodity) covers laboratory testing supplies and services for drug screening, occupational health, and forensic drug analysis that state and local governments are actively procuring. Recent solicitations show state and local buyers acquiring immunoassay screening kits, confirmatory testing materials (LC/MS/MS, GC/MS), collection supplies, urinalysis testing services, reference standards for forensic labs, and integrated drug testing programs tied to criminal justice, occupational health, and public health functions. The issuing bodies span state procurement offices, county departments (criminal justice, health services, forensic labs), cities, transit or health authorities, and educational institutions. Collin County Community Supervision and Corrections Department (Texas), Gwinnett County (Georgia), the Texas Comptroller of Public Accounts, Pinellas County (Florida), and Benton County (Oregon) each posted drug or forensic testing solicitations in recent months, reflecting demand across corrections, public health, forensic analysis, and occupational medicine programs.

Geographic activity is concentrated in Texas, Florida, Georgia, and Oregon, with additional recent solicitations from North Carolina, New Mexico, and Wisconsin. Representative opportunities include Collin County's RFP for offender specimen collection and drug testing services (RFP 2026-327, responses due July 23, 2026, estimated value $600,000 over two years with three optional renewals) covering immunoassay screening with confirmation and alternative matrices; the Texas Comptroller's IFB 304T-27-175A1.1 for proprietary laboratory consumables and drug screening reagents for statewide delivery (IFB, due October 20, 2026, serving the Texas Department of Public Safety); Benton County's RFQ for urinalysis testing services for Family Treatment Court (due July 7, 2026) requiring CLIA-certified labs with twice-weekly testing and 48–72-hour result turnaround; and Pinellas County's Invitation to Quote for certified drug reference standards for forensic lab validation (ITQ 26-0305-ITQ, due April 23, 2026, funded through the Paul Coverdell program). Pricing models range from per-test fees with volume-based panels to fixed unit costs for supplies and reagents; multi-year terms with annual renewal options are common. SBE and local vendor preferences appear in some solicitations. Recent activity shows sustained demand in corrections, public health, and forensic laboratory operations.